CNP Clinphone

RNS Number:3158J
ClinPhone plc
06 December 2007



                                 ClinPhone plc



                Final payment of shares to DataLabs shareholders





6 December 2007 - ClinPhone plc ("ClinPhone" or the "Company"), a leading
specialist supplier of technology solutions to the clinical trials industry,
announces that is has issued 732,779 new ClinPhone Shares as final payment of
the retained consideration to the shareholders of DataLabs Inc. following the
Company's acquisition of DataLabs which completed in November 2006.



For the purposes of published Earnings per Share calculations these shares have
been included within the Annual Report and Financial Statements for the period
ended 28 February 2007 within the weighted average number of shares of
57,071,000 and the Interim Report for the period ended 31 August 2007 within the
weighted average number of shares of 64,521,000.



ClinPhone's technology reduces the cost and duration of running clinical trials
and improves the accuracy, integrity and consistency of data collected.





Enquiries:


ClinPhone plc                                               +44 (0) 115 955 7333
Steve Kent, Chief Executive Officer
Scott Brown, Chief Financial Officer

Investec                                                    +44 (0) 20 7597 5970
Gary Clarence
Michael Lacey-Solymar

Financial Dynamics                                          +44 (0) 20 7831 3113
David Yates
Ben Brewerton









                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCKQLBBDLBZFBL

Clinphone (LSE:CNP)
Historical Stock Chart
From Jun 2024 to Jul 2024

Clinphone (LSE:CNP)
Historical Stock Chart
From Jul 2023 to Jul 2024